Donald Trump Sparks Medical Concerns by Linking Infant Paracetamol Use to Autism
Donald Trump has raised concerns among health experts after suggesting a possible connection between paracetamol use and autism in infants, prompting renewed scrutiny and debate within the medical community over the safety of common pain relievers.
TL;DR
White House Statements Ignite Scientific Outcry
A stir rippled through the scientific community on September 22, 2025, when Donald Trump, addressing reporters from the White House, sounded the alarm over paracetamol use during pregnancy. During a conference dedicated to autism, he repeatedly warned pregnant women against taking the widely used painkiller—also known as acetaminophen—and urged them not to administer it to their babies. According to Trump, this medication allegedly increased the risk of autism in children.
Lack of Scientific Consensus
Leading experts quickly pushed back against these assertions. “Dangerous” and “misleading” were some of the words used by Arthur Caplan, professor at NYU Langone Medical Center, who highlighted that such statements risk spreading misinformation and fueling needless anxiety among expectant mothers. The reality is that paracetamol remains the preferred pain reliever during pregnancy, unlike alternatives such as aspirin or ibuprofen.
Other authorities in the field, like David Mandell, acknowledged that while a handful of studies have explored potential associations, no causal link has ever been established between paracetamol exposure in utero and the development of autism. Parsing out these connections is notoriously complicated: researchers must distinguish between effects of the drug itself and those of underlying medical conditions for which it’s prescribed.
The Political Instrumentalization of Autism
From another angle, Trump’s rhetoric fits into a broader pattern. Throughout his administration, he has vowed to investigate what he refers to as an “autism epidemic.” Yet most specialists maintain that rising rates largely reflect improved recognition and diagnosis—not a true surge in cases. Genetic factors remain central in current research; environmental influences are still studied but neither vaccines nor paracetamol are regarded as culprits by mainstream science.
Adding fuel to an already contentious debate, Health Secretary Robert Kennedy Jr. recently reaffirmed his commitment to overhauling U.S. vaccination policy. He entrusted oversight of new autism research initiatives to a scientist widely criticized for holding discredited views about a supposed vaccine-autism connection.
Cautious Optimism for Future Research
In response to recent developments, dozens of American experts released an open letter urging restraint and rigor. They stressed several key points:
As political narratives swirl and uncertainties persist, many scientists stress one principle above all: let robust scientific inquiry—not speculation—guide our understanding of autism.